FDA Scientists Advised to Avoid Certain Terms

FDA scientists have been advised to stop using terms like 'woman,' 'disabled,' and 'elderly' in external communications, reportedly due to a misinterpretation of President Trump's executive orders against gender ideology. The list, which includes over two dozen words, has sparked confusion and concern among FDA staff, who claim it hampers their ability to perform their duties effectively. The White House has disputed the legitimacy of the list, attributing it to a misunderstanding of the executive orders. These orders, signed by Trump, emphasize recognizing biological gender and have led to broader directives affecting other federal health agencies, including the CDC. The removal of such terms could disrupt public health communications and research on diverse medical needs. Public health experts warn that this approach threatens the ability to address health issues affecting various groups, including those with HIV and sexually transmitted diseases.